Drew M. Pardoll, M.D., Ph.D.

Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University Medicine

Cancer Immunology

EDUCATION
BA – Johns Hopkins University
MD – Johns Hopkins University School of Medicine
PhD – Johns Hopkins University School of Medicine

AWARDS AND ACCOLADES
Cancer Research Institute Investigators Award
Medical Student Basic Science Teaching Award
National Academy of Inventors

COMPANIES AND BOARDS
Co-Founder – Amplimmune (acquired by MedImmune/AstraZeneca), Jounce (NAS:JNCE), Potenza (Acquired by Astellas), Tizona, Ervaxx, DNAtrix

Scientific Advisory Board – WindMil, Five Prime (NASDAQ:FPRX), DNAtrix, Dracen Pharmaceuticals, Aduro (NASDAQ:ADRO) Pharmaceuticals

MEMBER OF Investment Committee

Associated Portfolio Companies

WindMIL Therapeutics